IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 133 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $8,000 | -20.0% | 420 | -4.3% | 0.00% | 0.0% |
| Q3 2021 | $10,000 | -9.1% | 439 | +4.5% | 0.00% | 0.0% |
| Q2 2021 | $11,000 | -15.4% | 420 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $13,000 | -31.6% | 420 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $19,000 | +35.7% | 420 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $14,000 | +75.0% | 420 | -40.0% | 0.00% | -50.0% |
| Q3 2018 | $8,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,944,201 | $27,999,000 | 13.31% |
| Broadfin Capital, LLC | 4,328,303 | $41,162,000 | 8.50% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $52,945,000 | 5.24% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $20,811,000 | 5.01% |
| Avoro Capital Advisors LLC | 10,530,862 | $100,148,000 | 4.33% |
| Prosight Management, LP | 917,080 | $8,721,000 | 3.82% |
| Perceptive Advisors | 12,235,811 | $116,362,000 | 3.28% |
| Ghost Tree Capital, LLC | 1,150,000 | $10,937,000 | 2.86% |
| QVT Financial LP | 1,021,361 | $9,241,000 | 2.32% |
| Cheyne Capital Management (UK) LLP | 186,500 | $1,774,000 | 1.66% |